Mosaic Embryos: Should You Transfer?
Preimplantation genetic testing (PGT-A) was supposed to simplify the embryo selection decision. In many ways it has. But it also introduced a result category nobody anticipated having to navigate: mosaic. Not clearly normal, not clearly abnormal, but somewhere in between. For patients with mosaic embryos and no euploid alternatives, the decision of whether to transfer is one of the most consequential in the IVF process.
What Mosaicism Is (and What the Test Actually Measures)
Every PGT-A biopsy removes 5 to 10 cells from the trophectoderm, the outer cell layer that becomes the placenta. A mosaic result means those few cells showed a mixture of normal and abnormal chromosomal patterns. The percentage reported (e.g., "30% mosaic for trisomy 16") reflects the proportion of abnormal cells in that small sample.
This introduces two important uncertainties. First, the biopsy represents the trophectoderm, not the inner cell mass (ICM) that becomes the baby. The ICM may have a different chromosomal makeup. Second, a few cells may not accurately represent even the trophectoderm as a whole.
How Clinics Prioritize Mosaic Embryos
Most clinics that transfer mosaic embryos follow a tiered prioritization system. The hierarchy is based on the level and type of mosaicism detected.
| Priority | Mosaic Level | Estimated LBR per Transfer | Typical Recommendation |
|---|---|---|---|
| 1st | Euploid (no mosaicism) | 50 to 65% | Transfer first |
| 2nd | Low-level mosaic (<40%) | 40 to 50% | Transfer if no euploid available |
| 3rd | Moderate mosaic (40 to 60%) | 30 to 40% | Consider with genetic counseling |
| 4th | High-level mosaic (>60%) | 15 to 30% | Deprioritize; new cycle may be preferable |
| Last | Aneuploid (100% abnormal) | <5% | Not recommended for transfer |
Which Chromosomes Matter
Not all mosaic results carry the same clinical weight. Mosaicism involving certain chromosomes is considered lower risk:
- Lower concern: Chromosomes 1, 3, 4, 5, 6, 9, 10, 11, 12, 17, 19, 20 (rarely viable as full trisomies, so the abnormal cells are likely eliminated)
- Moderate concern: Chromosomes 2, 7, 8, 14, 15 (some can involve imprinting disorders)
- Higher concern: Chromosomes 13, 14, 15, 16, 18, 21, 22, X, Y (can survive as full trisomies and may cause uniparental disomy if the embryo self-corrects through trisomy rescue)
Self-Correction: What the Embryo Can Do
One of the most reassuring findings in mosaic research is that embryos appear to have built-in mechanisms for correcting or compartmentalizing abnormal cells. Abnormal cells may be outcompeted by normal cells during early development, pushed into the placental lineage rather than the fetal lineage, or eliminated through programmed cell death.
Follow-up data on babies born after mosaic embryo transfer has been consistently reassuring. Multiple series have reported that prenatal testing (CVS or amniocentesis) in mosaic-origin pregnancies shows normal results in the vast majority of cases, and newborn outcomes are comparable to those from euploid transfers.
The Decision Framework
Deciding whether to transfer a mosaic embryo depends on several factors that are specific to your situation:
- Do you have euploid embryos available? If yes, those are transferred first. The mosaic decision arises when euploid options are exhausted.
- What is the cost and likelihood of producing more euploid embryos? For patients with diminished ovarian reserve, another retrieval cycle may yield the same or worse results.
- What is the specific mosaic result? Low-level mosaicism on a low-concern chromosome is a very different situation from high-level mosaicism on chromosome 21.
- Are you willing to do prenatal diagnostic testing? Most clinics recommend CVS or amniocentesis after a mosaic transfer to confirm the pregnancy's chromosomal status.
- What are your values around uncertainty? Some patients are comfortable with the residual uncertainty; others are not. Neither response is wrong.
What to Ask Your Clinic
- What is your clinic's policy on mosaic embryo transfers?
- Can you refer me to a genetic counselor to discuss my specific PGT-A report?
- What prenatal testing do you recommend after a mosaic transfer?
- Have you tracked outcomes for mosaic transfers at your clinic specifically?
- If I have multiple mosaic embryos, how do you rank them for transfer priority?
Frequently Asked Questions
What does mosaic mean in PGT-A results?
A mosaic embryo has a mixture of chromosomally normal and abnormal cells in the biopsy sample. The reported percentage reflects the proportion of abnormal cells detected, but because PGT-A biopsies only a few cells from the outer layer (trophectoderm), the result may not represent the entire embryo.
Are mosaic embryos safe to transfer?
Research shows that low-level mosaics (under 40% abnormal cells) have clinical outcomes that approach those of euploid embryos, with healthy live birth rates reported in the range of 40 to 50% per transfer. High-level mosaics (above 50 to 60%) have lower success rates and are generally deprioritized.
Should I transfer a mosaic embryo before doing another IVF cycle?
This depends on your clinical situation. For patients with limited embryos, advanced age, or financial constraints, a low-level mosaic transfer may be more productive than another retrieval cycle. Discuss the specific mosaic pattern with a genetic counselor.
Will a baby born from a mosaic embryo have health problems?
Published data on babies born from mosaic embryo transfers is reassuring: the vast majority are chromosomally normal and healthy. The embryo appears to have mechanisms that correct or eliminate abnormal cells during development, a process called self-correction.
Do all clinics agree on mosaic transfer policies?
No. Policies vary significantly. Some clinics will not transfer any mosaic embryo. Others follow tiered prioritization (euploid first, low-mosaic second, high-mosaic last). Ask your clinic for their specific protocol and the reasoning behind it.
Ready for the Next Step?
Talk to a fertility coordinator who can walk you through protocol options, cost structures, and clinic comparisons. No pressure, no sponsorships.
Start a Conversation on WhatsApp